General Counsel · Alamar Biosciences, Inc. · Common Stock
Side
A
Value
—
Shares
29.0K
Price
—
Executed
Sep 14, 2026
Disclosed
Sep 16, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 14 executedSep 16, 2026 disclosed
ALMR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Brottem John L. filed this Form 4 reporting a grant or award of ALMR on Sep 14, 2026. It became public on Sep 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
General Counsel
Brottem John L.cik:0001823381
Issuer
Alamar Biosciences, Inc.cik:0002104204
Revision history · 0
No field has changed since this record was first ingested.
